Congenital Bronchial Artery to Pulmonary Artery Fistula Presenting as Hemoptysis

VanDerPloeg, Daniel G.; Strong, William R.; Krohmer, Steven; O’Connor, William N.; Martin, Jeremiah T.

doi:10.1016/j.athoracsur.2014.10.057

Cited by 9 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Systemic arteries supplying the lung, mainly bronchial arteries, often increase their flow to compensate for decreased lung perfusion [ 30 , 31 ]. However, under such scenarios, the communications between the systemic arteries and pulmonary micro-circulation are prone to bleeding [ 32 ]. In general, BAE in individuals with SPS was safe.…”

Section: Discussionmentioning

confidence: 99%

Development of a model to predict recurrence after bronchial artery embolization for non-cancer related hemoptysis

Yan

Huang

et al. 2021

BMC Pulm Med

View full text Add to dashboard Cite

Background Relapse after effective bronchial arterial embolization (BAE) for controlling hemoptysis is not uncommon. Studies reported diverse predictors of recurrence. However, a model to assess the probability of recurrence in non-cancer related hemoptysis patients after BAE has not been reported. This study was to develop a model to predict recurrence after BAE for non-cancer related hemoptysis. Methods The study cohort included 487 patients who underwent BAE for non-cancer-related hemoptysis between January 2015 and December 2019. We derived the model’s variables from univariate and multivariate Cox regression analyses. The model presented as a nomogram scaled by the proportional regression coefficient of each predictor. Model performance was assessed with respect to discrimination and calibration. Results One-month and 1-, 2-, 3- and 5-year recurrence-free rates were 94.5%, 88.0%, 81.4%, 76.2% and 73.8%, respectively. Risk factors for recurrence were underlying lung diseases and the presence of systemic arterial-pulmonary circulation shunts. This risk prediction model with two risk factors provided good discrimination (area under curve, 0.69; 95% confidence interval, 0.62–0.76), and lower prediction error (integrated Brier score, 0.143). Conclusion The proposed model based on routinely available clinical and imaging features demonstrates good performance for predicting recurrence of non-cancer-related hemoptysis after BAE. The model may assist clinicians in identifying higher-risk patients to improve the long-term efficacy of BAE.

show abstract

Section: Discussionmentioning

confidence: 99%

Development of a model to predict recurrence after bronchial artery embolization for non-cancer related hemoptysis

Yan

Huang

et al. 2021

BMC Pulm Med

View full text Add to dashboard Cite

show abstract

“…[ 1 2 ] Unlike pulmonary AVM, they do not have association with Osler–Weber–Rendu syndrome. [ 11 ] Bronchial arterial malformations can be acquired secondary to tuberculosis (TB), pneumonia, actinomycosis, neoplasm, or trauma. [ 12 ] In our index case, there was no history of TB, recent infection, or trauma.…”

Section: Discussionmentioning

confidence: 99%

“…[ 13 ] Due to systemic arterial supply, bronchial AVMs are more prone to rupture than pulmonary AVM and require more definitive management. [ 11 ] Angioembolization is usually the first-line treatment. Surgery is reserved for recurrent cases.…”

Section: Discussionmentioning

confidence: 99%

Bronchopulmonary arteriovenous malformation presenting as cryptogenic hemoptysis in a patient with bicuspid aortic valve

Gorsi

Sharma²,

Jugpal

et al. 2020

Lung India

View full text Add to dashboard Cite

We report the case of a 44-year-old male patient with bicuspid aortic valve, presenting with hemoptysis. Catheter angiography revealed an abnormal communication between bronchial and pulmonary artery, which remained undetected on computed tomography angiography. Angioembolization was done using polyvinyl alcohol and gelfoam particles. This is the first case in literature describing bronchial arteriovenous malformation associated with bicuspid aortic valve.

show abstract

“…This would be suitable in our case, but for the fact that the tortuosity of the feeding artery in our case would preclude the deployment of such a device. VanDerPloeg et al 2 and Kato et al 5 reported two similar cases that were successfully treated by video-assisted surgery that is more invasive than embolization.…”

Section: The Case They Described Had An Abnormal Bronchial Arterymentioning

confidence: 97%

A Case of Congenital Bronchial Pulmonary Arterial Malformation Successfully Treated by Embolization

Chu

Sit

Kwok

2018

J Clin Interv Radiol ISVIR

View full text Add to dashboard Cite

Idiopathic bronchial pulmonary arterial malformation (BPAM) is a very rare condition. The authors present a case of BPAM in which a right bronchial artery communicates with a main upper lobe branch of the right pulmonary artery. It was successfully treated by embolization in one setting. The patient remained asymptomatic and well during the follow-up period. The authors therefore conclude that if the embolic material/device is carefully chosen, it is a safe and effective means of treating BPAM.

show abstract

Congenital Bronchial Artery to Pulmonary Artery Fistula Presenting as Hemoptysis

Cited by 9 publications

References 5 publications

Development of a model to predict recurrence after bronchial artery embolization for non-cancer related hemoptysis

Development of a model to predict recurrence after bronchial artery embolization for non-cancer related hemoptysis

Bronchopulmonary arteriovenous malformation presenting as cryptogenic hemoptysis in a patient with bicuspid aortic valve

A Case of Congenital Bronchial Pulmonary Arterial Malformation Successfully Treated by Embolization

Contact Info

Product

Resources

About